Westlake Chemical Partners LP
WLKP
$18.96
-$0.10-0.53%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.13B | 1.10B | 1.09B | 1.14B | 1.14B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.13B | 1.10B | 1.09B | 1.14B | 1.14B |
| Cost of Revenue | 777.86M | 728.44M | 711.79M | 710.74M | 722.07M |
| Gross Profit | 355.84M | 373.36M | 377.06M | 425.16M | 421.04M |
| SG&A Expenses | 27.78M | 27.59M | 28.89M | 28.50M | 29.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 805.64M | 756.03M | 740.68M | 739.23M | 751.87M |
| Operating Income | 328.07M | 345.78M | 348.17M | 396.67M | 391.24M |
| Income Before Tax | 302.26M | 320.32M | 322.55M | 369.99M | 369.67M |
| Income Tax Expenses | 556.00K | 730.00K | 732.00K | 835.00K | 839.00K |
| Earnings from Continuing Operations | 301.71 | 319.59 | 321.82 | 369.16 | 368.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -252.55M | -266.95M | -269.32M | -306.77M | -307.13M |
| Net Income | 49.16M | 52.64M | 52.51M | 62.39M | 61.70M |
| EBIT | 328.07M | 345.78M | 348.17M | 396.67M | 391.24M |
| EBITDA | 448.97M | 460.92M | 459.14M | 508.57M | 503.96M |
| EPS Basic | 1.40 | 1.50 | 1.49 | 1.78 | 1.76 |
| Normalized Basic EPS | -1.70 | -1.79 | -1.82 | -2.04 | -2.17 |
| EPS Diluted | 1.40 | 1.50 | 1.49 | 1.78 | 1.76 |
| Normalized Diluted EPS | -1.70 | -1.79 | -1.82 | -2.04 | -2.17 |
| Average Basic Shares Outstanding | 140.59M | 140.59M | 140.58M | 140.57M | 140.57M |
| Average Diluted Shares Outstanding | 140.59M | 140.59M | 140.58M | 140.57M | 140.57M |
| Dividend Per Share | 1.89 | 1.89 | 1.89 | 1.89 | 1.89 |
| Payout Ratio | 135.18% | 126.23% | 126.53% | 106.48% | 107.68% |